Perrigo Moves In On Major Generic Firms With Agis Acquisition
This article was originally published in The Tan Sheet
Executive Summary
Perrigo's acquisition of Israeli generic drug firm Agis Pharmaceuticals will put the combined entity's annualized sales over the $1 bil. mark and in the same league with major Rx generic drug players